GL検索 v0.1.0
画像は 94 ページを描画したものです
page 94

p.94 抽出テキスト

Failure Association of the European Society of Cardiology. Eur J Heart Fail 2023;25:776–91. https://doi.org/10.1002/ejhf.2874 445. Antohi LE, Adamo M, Chioncel O. Long-term survival after acute heart failure hospitalization: from observation to collaborative interventions. Eur J Heart Fail 2022;24:1529–31. https://doi.org/10.1002/ejhf.2645 446. Maggioni AP, Dahlstrom U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2010;12:1076–84. https://doi.org/ 10.1093/eurjhf/hfq154 447. Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C, et al. Acute heart failure congestion and perfusion status—impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail 2019; 21:1338–52. https://doi.org/10.1002/ejhf.1492 448. Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W, et al. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Glob Health 2020;8:e411–22. https:// doi.org/10.1016/S2214-109X(20)30004-8 449. Logeart D, Isnard R, Resche-Rigon M, Seronde MF, de Groote P, Jondeau G, et al. Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail 2013;15:465–76. https://doi.org/10.1093/eurjhf/hfs189 450. Taylor CJ, Ordonez-Mena JM, Roalfe AK, Lay-Flurrie S, Jones NR, Marshall T, et al. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000–2017: population based cohort study. BMJ 2019;364:l223. https://doi.org/10.1136/bmj.l223 451. Butt JH, Fosbol EL, Gerds TA, Andersson C, McMurray JJV, Petrie MC, et al. Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort. Eur J Heart Fail 2020;22:1777–85. https://doi.org/10.1002/ejhf.1800 452. Miro O, Garcia Sarasola A, Fuenzalida C, Calderon S, Jacob J, Aguirre A, et al. Departments involved during the first episode of acute heart failure and subsequent emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort. Eur J Heart Fail 2019;21:1231–44. https:// doi.org/10.1002/ejhf.1567 453. Javaloyes P, Miro O, Gil V, Martin-Sanchez FJ, Jacob J, Herrero P, et al. Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes. Eur J Heart Fail 2019; 21:1353–65. https://doi.org/10.1002/ejhf.1502 454. Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail 2016;18:613–25. https://doi.org/10.1002/ejhf.566 455. Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2017;19:1242–54. https://doi.org/10.1002/ejhf.890 456. Chatur S, Vaduganathan M, Claggett BL, Cunningham JW, Docherty KF, Desai AS, et al. Outpatient worsening among patients with mildly reduced and preserved ejection fraction heart failure in the DELIVER trial. Circulation 2023;148:1735–45. https://doi.org/10.1161/CIRCULATIONAHA.123. 066506 457. Ambrosy AP, Parikh RV, Sung SH, Tan TC, Narayanan A, Masson R, et al. Analysis of worsening heart failure events in an integrated health care system. J Am Coll Cardiol 2022;80:111–22. https://doi.org/10.1016/j.jacc. 2022.04.045 458. Madelaire C, Gustafsson F, Stevenson LW, Kristensen SL, Kober L, Andersen J, et al. One-year mortality after intensification of outpatient diuretic therapy. J Am Heart Assoc 2020;9:e016010. https://doi.org/10.1161/JAHA.119. 016010 459. Okumura N, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, et al. Importance of clinical worsening of heart failure treated in the outpatient setting: evidence from the prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure trial (PARADIGM-HF). Circulation 2016;133:2254–62. https://doi.org/10.1161/ CIRCULATIONAHA.115.020729 460. Packer M, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ, et al. Effect of empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction: EMPEROR-Preserved trial. Circulation 2021;144:1284–94. https://doi.org/10.1161/CIRCULATIONAHA.121. 056824 461. Skali H, Dwyer EM, Goldstein R, Haigney M, Krone R, Kukin M, et al. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT. Eur J Heart Fail 2014;16:560–5. https://doi.org/10.1002/ejhf.71 462. Vaduganathan M, Cunningham JW, Claggett BL, Causland FM, Barkoudah E, Finn P, et al. Worsening heart failure episodes outside a hospital setting in heart failure with preserved ejection fraction: the PARAGON-HF trial. JACC Heart Fail 2021;9:374–82. https://doi.org/10.1016/j.jchf.2021.01.014 463. Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, et al. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol 2017;69:3042–51. https://doi.org/10. 1016/j.jacc.2017.04.042 464. Harjola VP, Parissis J, Brunner-La Rocca HP, Celutkiene J, Chioncel O, Collins SP, et al. Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 2018; 20:1081–99. https://doi.org/10.1002/ejhf.1204 465. Zymlinski R, Biegus J, Sokolski M, Siwolowski P, Nawrocka-Millward S, Todd J, et al. Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion. Eur J Heart Fail 2018;20:1011–8. https://doi.org/10.1002/ejhf.1156 466. Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J, et al. Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Eur J Heart Fail 2023;25:616–31. https://doi.org/10. 1002/ejhf.2848 467. Walkley R, Allen AJ, Cowie MR, Maconachie R, Anderson L. The costeffectiveness of NT-proBNP for assessment of suspected acute heart failure in the emergency department. ESC Heart Fail 2023;10:3276–86. https://doi. org/10.1002/ehf2.14471 468. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647–54. https://doi.org/10.1056/ NEJMoa031681 469. Roberts E, Ludman AJ, Dworzynski K, Al-Mohammad A, Cowie MR, McMurray JJ, et al. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ 2015;350:h910. https://doi.org/10.1136/bmj.h910 470. Chiu L, Jairam MP, Chow R, Chiu N, Shen M, Alhassan A, et al. Meta-analysis of point-of-care lung ultrasonography versus chest radiography in adults with symptoms of acute decompensated heart failure. Am J Cardiol 2022; 174:89–95. https://doi.org/10.1016/j.amjcard.2022.03.022 471. Lian R, Zhang GC, Yan ST, Sun LC, Zhang SQ, Zhang GQ. Role of ultrasound lung comets in the diagnosis of acute heart failure in emergency department: a systematic review and meta-analysis. Biomed Environ Sci 2018;31: 596–607. https://doi.org/10.3967/bes2018.081 472. Martindale JL, Secko M, Kilpatrick JF, deSouza IS, Paladino L, Aherne A, et al. Serial sonographic assessment of pulmonary edema in patients with hypertensive acute heart failure. J Ultrasound Med 2018;37:337–45. https://doi. org/10.1002/jum.14336 473. Gargani L, Girerd N, Platz E, Pellicori P, Stankovic I, Palazzuoli A, et al. Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging 2023;24:1569–82. https://doi.org/10.1093/ehjci/ jead169 474. Chioncel O, Parissis J, Mebazaa A, Thiele H, Desch S, Bauersachs J, et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock—a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:1315–41. https://doi.org/10.1002/ejhf.1922 475. Rossello X, Bueno H, Gil V, Jacob J, Martin-Sanchez FJ, Llorens P, et al. Synergistic impact of systolic blood pressure and perfusion status on mortality in acute heart failure. Circ Heart Fail 2021;14:e007347. https://doi.org/ 10.1161/CIRCHEARTFAILURE.120.007347 476. Filippatos G, Angermann CE, Cleland JGF, Lam CSP, Dahlstrom U, Dickstein K, et al. Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. JAMA Cardiol 2020;5: 401–10. https://doi.org/10.1001/jamacardio.2019.5108 477. Masip J, Peacock WF, Price S, Cullen L, Martin-Sanchez FJ, Seferovic P, et al. Indications and practical approach to non-invasive ventilation in acute heart failure. Eur Heart J 2018;39:17–25. https://doi.org/10.1093/eurheartj/ ehx580 478. Chioncel O, Collins SP, Ambrosy AP, Gheorghiade M, Filippatos G. Pulmonary oedema—therapeutic targets. Card Fail Rev 2015;1:38–45. https://doi.org/ 10.15420/CFR.2015.01.01.38 Downloaded from academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag100/8766302 by guest on 31 August 2026